Sign in
4

Changes in Ownership

Lantern Pharma Inc. Filed Acc 0001493152-25-014612

Options or other derivatives

  • Chief Financial Officer acquired 104,400 shares (grant or award)
  • Chief Financial Officer returned 104,400 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Margrave David R. · Chief Financial Officer

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2020-06-15 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −78,300 0 D
2020-06-15 Grant or award : show line 2 in the form Stock Option (Right to Buy) +78,300 78,300 D
2021-10-29 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −26,100 0 D
2021-10-29 Grant or award : show line 4 in the form Stock Option (Right to Buy) +26,100 26,100 D
Loading xslF345X05/ownership.xml…